CaaMTech’s Psychedelic Functional Unblinding Strategy Gets Regulatory Blessing
CaaMTech’s New Clinical Trial Design Solves the Emergent Functional Unblinding Problems Plaguing Psychedelic Medicine Developers ISSAQUAH, WA / ACCESSWIRE / November 14, 2024 / CaaMTech, Inc. is pleased to announce…
